![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 239/48 | (2006.01) |
A61K 31/506 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2509963 |
(13) | Kind of document | T |
(96) | European patent application number | 10788479.3 |
Date of filing the European patent application | 2010-12-06 | |
(97) | Date of publication of the European application | 2012-10-17 |
(45) | Date of publication and mention of the grant of the patent | 2015-11-25 |
(46) | Date of publication of the claims translation | 2016-02-25 |
(86) | Number | PCT/US2010/059108 |
Date | 2010-12-06 |
(87) | Number | WO 2011/071821 |
Date | 2011-06-16 |
(30) | Number | Date | Country code |
267155 P | 2009-12-07 | US |
(72) |
BERGHAUSEN, Joerg, CH
KAPA, Prasad, Koteswara, US
MCKENNA, Joseph, US
SLADE, Joel, US
WU, Raeann, US
DU, Zhengming, US
STOWASSER, Frank, CH
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | 3-(2,6-Dichlor-3,5-dimetoksi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenilamino]-pirimidin-4-il}-1-metil-karbamido ir jo druskų kristalinės formos |
CRYSTALLINE FORMS OF 3-(2,6-DICHLORO-3,5-DIMETHOXY-PHENYL)-1-{6-[4-(4-ETHYL-PIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL}-1-METHYL-UREA AND SALTS THEREOF. |
Payment date | Validity (years) | Amount | |
2024-11-19 | 15 | 289.00 EUR |
2025-12-06 |